Germany touts legal action on AstraZeneca over COVID-19 vaccine delays

By Nikita Chaurasia  Date: 2021-02-02

Germany touts legal action on AstraZeneca over COVID-19 vaccine delays

Germany’s government has reportedly threatened legal action against pharmaceutical laboratories for failing to deliver COVID-19 vaccines to the European Union on schedule. The recent development comes amidst high tensions regarding vaccine delays from AstraZeneca plc, a British-Swedish pharmaceutical giant.

For those unaware, there has been a growing unease between AstraZeneca and European leaders, after the drug-maker had fallen behind on its promise of delivering enough COVID-19 vaccine to the region. The pharmaceutical giant had claimed that it could now only deliver a quarter of the assured vaccine doses owing to some issues in one of its European factories.

German Economy Minister Peter Altmaier mentioned in a statement that if the pharma companies do not comply with their obligations, the country will be forced to undertake legal action. He added that the regional companies cannot favor other countries over the European Union.

Brussels has also accused AstraZeneca of giving partial treatment to the United Kingdom for the delivery of its COVID-19 vaccine at the expense of the European Union, sources claimed.

The EU had briefly threatened to limit vaccine exports to Northern Ireland by intervening in a part of the Brexit deal with Britain that enabled the free flow of goods over the Irish border.

It is also worth noting that AstraZeneca is not the only drug-maker in the firing line. Sources confirmed that Italy had threatened legal action against Pfizer Inc., an American pharmaceutical company, over vaccine delivery delays.

Sources confirmed that the European Medicines Agency has recently approved the COVID-19 vaccine developed by AstraZeneca for use in the European Union, after clearing Coronavirus vaccines from Pfizer-BioNtech as well as Moderna Inc.

Speaking of which, American multinational pharmaceutical company Pfizer Inc. has reportedly vowed to deliver around 75 million COVID-19 vaccine doses to the European Union by spring of 2021.

Source Credits –

https://www.firstpost.com/world/germany-threatens-legal-action-as-tensions-rise-between-eu-and-astrazeneca-over-covid-19-vaccine-delays-9257381.html

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

U.K. might ease lockdown restrictions following drop in COVID-19 cases

U.K. might ease lockdown restrictions following drop in COVID-19 cases

By Nikita Chaurasia

British Prime Minister Boris Johnson is reportedly planning to further ease lockdown restrictions in the United Kingdom. This announcement comes after Britain witnessed a drop in the daily death toll and case count, primarily due to rapid vaccination...

Maruti Suzuki India prolongs maintenance shutdown over COVID-19 fears

Maruti Suzuki India prolongs maintenance shutdown over COVID-19 fears

By Nikita Chaurasia

Maruti Suzuki India Limited has reportedly extended its maintenance shutdown from May 9th to May 16th amidst rising COVID-19 cases across the country. However, it is difficult to ascertain whether the intention behind the extended shutdown is to guar...

Amazon sets tougher rules for its delivery service partners’ employees

Amazon sets tougher rules for its delivery service partners’ employees

By Nikita Chaurasia

Amazon is known for closely managing its staff and contractors, and it also seeks to control the employees of the companies in which it works. Reportedly, the company has updated its policies for Amazon’s delivery partners wherein it lays out d...

BMW, Ford lead Solid Power’s USD 130 million Series B funding round

BMW, Ford lead Solid Power’s USD 130 million Series B funding round

By Nikita Chaurasia

Solid Power Inc., a leading U.S-based producer of solid-state batteries has reportedly secured USD 130 million in the Series B funding round led by renowned car makers namely Ford Motor Company and BMW Group.  These funds will be used to develo...

Pfizer donates COVID-19 treatment drugs worth USD 70 million to India

Pfizer donates COVID-19 treatment drugs worth USD 70 million to India

By Nikita Chaurasia

Reportedly, American multinational pharmaceutical firm Pfizer Inc. has extended a helping hand to India in the battle against Covid-19, sending drugs worth USD 70 million to the country. The company is also in discussion with the Indian government to...